DCGI approves advanced trials for Biological E. Limited’s COVID- 19 vaccine
New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator…
Tag: DCGI
New collaboration for affordable COVID-19 drug 2-DG
New Delhi: Indian Institute of Chemical Technology (IICT), Hyderabad, a constituent laboratory of Council of Scientific and Industrial Research (CSIR),…
Anti-COVID drug ‘Colchicine’ cleared for phase 2 clinical trials
New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the…